focus -WSS

focus

author：focus 2025-09-30 14:09:03 - browse：36

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： The SUPPORT Act is critical to fighting the opioid crisis

WSS

The SUPPORT Act is critical to fighting the opioid crisis

Astellas still sees hope in its gene therapy after four deaths

Does good food count as health care? Study aims to find out

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Three issues to watch in global health in 2024

Caregivers of transplant patients call for more support, training

Wikipedia

focus

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CRISPR pioneers react to Casgevy, first gene

At least 13 dead in Texas as scorching temps continue

New Medicare drug pricing powers could soon be upended in court

Guidelines to prevent youth baseball injuries need more muscle

Idaho abortion case may prompt more restrictions in other states

After affirmative action ruling, medical educators look to 'holistic review'

Ransomware attacks on hospitals: Study outlines patient impact

explore

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Designating disabled people as health disparity population is crucial

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

NYU radiologists take on the challenge of expensive MRI machines

New Medicare drug pricing powers could soon be upended in court

knowledge

hotspot

knowledge

focus